Chemoinformaics analysis of (+)-Abscissic-Acid
| Molecular Weight | 292.375 | nRot | 4 |
| Heavy Atom Molecular Weight | 268.183 | nRig | 10 |
| Exact Molecular Weight | 292.167 | nRing | 1 |
| Solubility: LogS | -2.931 | nHRing | 0 |
| Solubility: LogP | 2.945 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 45 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 47.601 |
| nHD | 1 | BPOL | 27.549 |
| QED | 0.491 |
| Synth | 3.688 |
| Natural Product Likeliness | 2.304 |
| NR-PPAR-gamma | 0.121 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.722 |
| Pgp-sub | 0.005 |
| HIA | 0.01 |
| CACO-2 | -4.656 |
| MDCK | 0.0000364 |
| BBB | 0.728 |
| PPB | 0.847524 |
| VDSS | 1.498 |
| FU | 0.128765 |
| CYP1A2-inh | 0.124 |
| CYP1A2-sub | 0.396 |
| CYP2c19-inh | 0.907 |
| CYP2c19-sub | 0.828 |
| CYP2c9-inh | 0.726 |
| CYP2c9-sub | 0.161 |
| CYP2d6-inh | 0.086 |
| CYP2d6-sub | 0.131 |
| CYP3a4-inh | 0.346 |
| CYP3a4-sub | 0.74 |
| CL | 6.548 |
| T12 | 0.715 |
| hERG | 0.036 |
| Ames | 0.016 |
| ROA | 0.501 |
| SkinSen | 0.941 |
| Carcinogencity | 0.573 |
| EI | 0.092 |
| Respiratory | 0.698 |
| NR-Aromatase | 0.735 |
| Antiviral | Yes |
| Prediction | 0.686048 |